2027 China FIC Innovation & Collaboration Summit

China’s biopharmaceutical industry is shifting from scale-driven growth to high-quality innovation, with globally competitive R&D capabilities and a growing portfolio of mid-to-late-stage first-in-class and best-in-class candidates addressing unmet clinical needs. As Chinese innovation becomes increasingly integral to global drug development, international collaboration is unlocking shared value through differentiated assets, accelerated commercialization, and broader patient access. As a platform extending beyond a single event, ChinaFIC connects China’s most promising innovations with global partners. Returning during JPM Week on January 10, 2027, the second China FIC Innovation & Collaboration Summit will showcase the quality and breadth of China’s innovation pipeline and translate scientific potential into meaningful partnerships and shared success.